Northeast Pharmaceutical Group Co Ltd (000597) — Cash Flow Quality Index
Northeast Pharmaceutical Group Co Ltd (000597) has a Cash Flow Quality Index of 6.30x as of September 2025. Operating cash flow of CN¥274.09 Million exceeds net income of CN¥43.52 Million, indicating high earnings quality where cash backs reported profits. Explore Northeast Pharmaceutical Group Co Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Northeast Pharmaceutical Group Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Northeast Pharmaceutical Group Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Northeast Pharmaceutical Group Co Ltd (000597) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Northeast Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Northeast Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see market cap of Northeast Pharmaceutical Group Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.25x | CN¥1.11 Billion | CN¥260.07 Million | ▲ +129.8% |
| 2024 | 1.85x | CN¥758.76 Million | CN¥409.85 Million | ▲ +13.1% |
| 2023 | 1.64x | CN¥586.75 Million | CN¥358.46 Million | ▼ -47.3% |
| 2022 | 3.10x | CN¥1.11 Billion | CN¥357.05 Million | ▼ -60.3% |
| 2021 | 7.82x | CN¥746.51 Million | CN¥95.44 Million | ▼ -85.2% |
| 2020 | 52.73x | CN¥570.92 Million | CN¥10.83 Million | ▲ +2448.8% |
| 2019 | 2.07x | CN¥352.60 Million | CN¥170.44 Million | ▲ +46.1% |
| 2018 | 1.42x | CN¥285.09 Million | CN¥201.37 Million | ▲ +143.3% |
| 2017 | -3.27x | CN¥-301.20 Million | CN¥92.06 Million | ▼ -122.4% |
| 2016 | 14.60x | CN¥384.51 Million | CN¥26.35 Million | ▲ +2503.4% |
| 2014 | 0.56x | CN¥46.99 Million | CN¥83.82 Million | ▼ -92.1% |
| 2012 | 7.05x | CN¥86.09 Million | CN¥12.21 Million | ▲ +57.8% |
| 2010 | 4.47x | CN¥255.96 Million | CN¥57.27 Million | ▲ +245.5% |
| 2009 | 1.29x | CN¥615.91 Million | CN¥476.08 Million | ▼ -34.7% |
| 2008 | 1.98x | CN¥709.03 Million | CN¥357.94 Million | ▼ -53.1% |
| 2007 | 4.23x | CN¥198.56 Million | CN¥46.99 Million | ▲ +178.2% |
| 2006 | -5.40x | CN¥-106.00 Million | CN¥19.63 Million | ▼ -164.7% |
| 2005 | 8.34x | CN¥111.40 Million | CN¥13.35 Million | ▼ -67.9% |
| 2004 | 25.96x | CN¥211.06 Million | CN¥8.13 Million | ▼ -2.3% |
| 2003 | 26.57x | CN¥230.08 Million | CN¥8.66 Million | ▲ +72.0% |
| 2002 | 15.45x | CN¥157.41 Million | CN¥10.19 Million | ▲ +98.1% |
| 2001 | 7.80x | CN¥78.84 Million | CN¥10.11 Million | ▲ +522.4% |
| 2000 | 1.25x | CN¥36.13 Million | CN¥28.84 Million | ▼ -0.5% |
| 1999 | 1.26x | CN¥54.62 Million | CN¥43.38 Million | ▲ +1233.2% |
| 1998 | -0.11x | CN¥-7.59 Million | CN¥68.35 Million | — |